ArticleBMC health services research2025
Co-design of a multifaceted intervention to improve quality handover of medicine information at discharge from hospital.
Article in BMC health services research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Evaluating time-based outcomes of a pharmacist-doctor collaborative discharge medication reconciliation model: an observational study.International journal of clinical pharmacy · 2026Observational
- Implementation of a pharmacist‑led discharge intervention to improve medication information handover at hospital discharge: a non-randomised feasibility study.BMC health services research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundTimely and accurate discharge medicine information is essential for primary care clinicians, including general practitioners and community pharmacists, to provide safe and effective post-discharge care. Inadequate handover of discharge medicines poses risks of medication-related harm, compromising patient safety and leads to hospital readmissions. This study aimed to develop a multifaceted intervention targeting older patients (>65 years) to enhance medicine handover at hospital discharge.
methodsFollowing an initial consensus-building workshop, a structured five-step co-design process was implemented. Step 1 involved workshops and interviews with hospital clinicians, hospital leadership, primary care providers, and consumers experienced in discharge medicine handover. Stakeholder input in Step 2 refined intervention components and developed training materials. Step 3 obtained endorsement from health service decision makers and governance approvals. Step 4 included pharmacist upskilling, end-user testing, and feedback collection. Step 5 finalised intervention components and constructed a Logic Model.
resultsSeventy-eight stakeholders participated in workshops and interviews from August to November 2023. Four key medicine handover objectives for older patients emerged, which were operationalised into intervention recommendations over a five-month period (December 2023-April 2024). Component 1 empowered patients to query clinicians about their medications via a dedicated website with a question builder and evidence-based resources. Component 2 involved training doctors to document reasons for medicine changes in patient records. Component 3 implemented patient risk stratification to guide tailored strategies for communication to primary care clinicians. Component 4 focused on discharge reconciliation planning by unit pharmacists in collaboration with physicians. End-user testing yielded positive feedback.
conclusionsA co-designed multifaceted intervention was developed to enhance medicine handover during hospital discharge. The intervention will undergo feasibility testing to assess its impact on reducing medication-related harm and hospital readmissions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.